Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data. - Wikidata - wikimedia - TriplyDB

Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.

Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.

http://www.wikidata.org/entity/Q31005025

about

Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients.Does Regular Use of a Complementary Medicine of Olea Europe and Ficus carica Have Adverse Effects on Lipid Profile and Fasting Blood Glucose of Rheumatoid Arthritis (RA) Patients Under Treatment with DMARD Regimens Containing Methotrexate?Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk.The level of proinflammatory cytokines: interleukins 12, 23, 17 and tumor necrosis factor α in patients with metabolic syndrome accompanying severe psoriasis and psoriatic arthritis

P2860

Q36027291-66783E0C-95DA-4C3D-B4C1-0EE33FCDFEDC Q37651150-E159A46D-8F4F-4651-A6CF-5B8D4469F83E Q38737288-BAC04417-AA86-4A8A-BBC7-9AC93BBE36FA Q58727105-24C6933B-6E58-45A5-A5BC-31A5017DF399

P2860

Protective effects of methotrexate against ischemic cardiovascular disorders in patients treated for rheumatoid arthritis or psoriasis: novel therapeutic insights coming from a meta-analysis of the literature data.

http://www.wikidata.org/entity/Q31005025

description

2015 nî lūn-bûn

@nan

2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Protective effects of methotre ...... alysis of the literature data.

@ast

Protective effects of methotre ...... alysis of the literature data.

@en

type

label

Protective effects of methotre ...... alysis of the literature data.

@ast

Protective effects of methotre ...... alysis of the literature data.

@en

prefLabel

Protective effects of methotre ...... alysis of the literature data.

@ast

Protective effects of methotre ...... alysis of the literature data.

@en

P1433

Q31005025-2273E4D0-0FAB-446C-8E7E-27AA28067A84

P1476

Q31005025-1D0608E7-6C65-4CFE-9359-CED53F4F1FA3

P2093

Q31005025-42D6CEE3-05DF-40E8-A672-55796F44A8C4

Q31005025-C2025C7C-0AE3-47B2-9ED3-EDA0FF47CBA0

Q31005025-EBB8A753-6607-4428-941D-BD7B06F2F4A1

P2860

Q31005025-05D8D49E-CBF0-46AC-A144-3A48E65ECDD1

Q31005025-13474D2B-9878-49D0-9622-AE2F0454F312

Q31005025-1C2A9601-632D-453F-9B07-7A2CF04F6AEE

Q31005025-243804C6-D475-4D90-9513-0022BF4F021F

Q31005025-26CD2C0E-E3A0-4B3C-BAE8-B62D43A14A77

Q31005025-287F3CF5-152D-4130-B284-73EA25946EED

Q31005025-3DC49093-F5C3-4D72-A686-A30CCDFA8FB7

Q31005025-3ECF4299-C3A7-476C-9517-0BB6B4F2B505

Q31005025-3EEC2F51-1105-4D2B-9F08-AE6813AB382E

Q31005025-448E5A85-AF3C-4FCA-9680-31ED8F16B31E

P304

Q31005025-067573F0-76E1-4F87-95EC-5557844AE837

P31

Q31005025-16311010-1235-4CD4-BFD8-3F1C23CB6D03

Q31005025-530796ab-68e9-4a66-ab6f-461356fedb77

P356

Q31005025-0CBF84DB-CFD7-405F-96D9-AFE381A730D0

P433

Q31005025-20C3C21E-6686-4D5E-95F1-21CE04E14C18

P478

Q31005025-6CBF8477-D9D3-4FD2-A87F-6ACB52E27FAD

P577

Q31005025-EEDBC738-F674-4E97-A086-54EF152447AD

P698

Q31005025-0AB292DE-BF12-4106-8863-F0418F665E94

P932

Q31005025-FFFF0F94-0206-46ED-9092-FF5ACCE2E217

P356

P1433

Anatolian journal of cardiology

P1476

Protective effects of methotre ...... alysis of the literature data.

@en

P2093

Cesare Baldi

http://www.w3.org/2001/XMLSchema#string

Leonardo Palmisani

http://www.w3.org/2001/XMLSchema#string

Renato De Vecchis

http://www.w3.org/2001/XMLSchema#string

P2860

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability.

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

C-Reactive Protein and secondary prevention of coronary events.

Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis.

Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study.

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.

P304

2-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5152/AKD.2015.6136

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26467356

http://www.w3.org/2001/XMLSchema#string

P932

5336700

http://www.w3.org/2001/XMLSchema#string